EPISODE · Mar 31, 2025 · 27 MIN
CERo Therapeutics - $CERO - Ep:033 - Nano Cap Podcast
from Nano Cap Podcast · host Will Tjernlund
In this conversation, Chris Ehrlich, CEO of CERo Therapeutics, shares his extensive experience in the biotech industry, particularly in cancer treatment and immunotherapy. He discusses the challenges and opportunities within the biotech landscape, including the process of going public, valuations, and the unique aspects of developing T-cell therapeutics. Chris emphasizes the importance of innovation in cancer treatment and outlines the future aspirations for CERo Therapeutics as they move towards clinical trials.CERo Therapeutics Website https://www.cero.bio/Nano Cap Podcast Website https://www.nanocappod.com/
What this episode covers
In this conversation, Chris Ehrlich, CEO of CERo Therapeutics, shares his extensive experience in the biotech industry, particularly in cancer treatment and immunotherapy. He discusses the challenges and opportunities within the biotech landscape, including the process of going public, valuations, and the unique aspects of developing T-cell therapeutics. Chris emphasizes the importance of innovation in cancer treatment and outlines the future aspirations for CERo Therapeutics as they move towards clinical trials.CERo Therapeutics Website https://www.cero.bio/Nano Cap Podcast Website https://www.nanocappod.com/
NOW PLAYING
CERo Therapeutics - $CERO - Ep:033 - Nano Cap Podcast
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.